Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common Growth (3y) (2012 - 2018)
Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common Growth (3y) (2012 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.83% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.96% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -65.41% |
| Dec 31, 2017 | -31.61% |
| Sep 30, 2017 | -25.21% |
| Jun 30, 2017 | 4.89% |
| Mar 31, 2017 | 5.94% |
| Dec 31, 2016 | 7.83% |
| Sep 30, 2016 | 8.80% |
| Jun 30, 2016 | 4.97% |
| Mar 31, 2016 | 2.99% |
| Dec 31, 2015 | 10.66% |
| Sep 30, 2015 | 6.59% |
| Jun 30, 2015 | 7.78% |
| Mar 31, 2015 | 18.56% |
| Dec 31, 2014 | 12.70% |
| Sep 30, 2014 | 12.96% |
| Jun 30, 2014 | 13.78% |
| Mar 31, 2014 | 12.75% |
| Dec 31, 2013 | 17.07% |
| Sep 30, 2013 | 16.49% |
| Jun 30, 2013 | 17.79% |